Rheumatoid Arthritis



Anxiety Depression and Rheumatoid Arthritis


Condition:   Rheumatoid Arthritis
Intervention:   Other: Anxiety or depression
Sponsor:   Sichuan Provincial People's Hospital
Not yet recruiting - verified April 2017


The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis


Condition:   RheumatoId Arthritis
Intervention:   Device: Hyperbaric Oxygen
Sponsor:   David Grant U.S. Air Force Medical Center
Enrolling by invitation - verified December 2016


A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics


Condition:   Rheumatoid Arthritis
Interventions:   Drug: E6011;   Drug: Placebo
Sponsor:   Eisai Co., Ltd.
Recruiting - verified March 2017


A Dose Response Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Methotrexate


Condition:   Rheumatoid Arthritis
Interventions:   Drug: E6011;   Drug: Placebo
Sponsor:   Eisai Co., Ltd.
Recruiting - verified March 2017


Rheumatoid Arthritis Patients and Porphyromonas Gingivalis


Condition:   Rheumatoid Arthritis
Interventions:   Procedure: blood sample;   Procedure: synovial tissue
Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
Recruiting - verified January 2017


Oral Metagenomic Biomarkers in Rheumatoid Arthritis


Condition:   Rheumatoid Arthritis
Interventions:   Procedure: Dental Plaque;   Other: Multi-dimensional health assessment questionnaire (MDHAQ);   Other: Saliva Collection
Sponsors:   University of Florida;   United States Department of Defense;   VA Medical Center-Gainesville
Recruiting - verified February 2017


Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients


Condition:   Rheumatoid Arthritis
Interventions:   Biological: VAY736;   Biological: VAY736 placebo
Sponsor:   Novartis Pharmaceuticals
Active, not recruiting - verified April 2017


Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis to Adapt Treatment


Condition:   Rheumatoid Arthritis
Interventions:   Device: Xrays;   Device: Ultrasound (B mode );   Device: Ultrasound (D mode)
Sponsor:   University Hospital, Brest
Recruiting - verified January 2017


Reduced Ultrasound Counts in Rheumatoid Arthritis


Condition:   Rheumatoid Arthritis
Intervention:  
Sponsors:   Hospital General Universitario Gregorio Marañon;   Roche Pharma AG
Recruiting - verified April 2017


Incorporation of Patient Reported Outcomes Data in the Care of US Veterans With Rheumatoid Arthritis


Condition:   Rheumatoid Arthritis
Interventions:   Other: PRO data utilized;   Other: PRO data not utilized
Sponsors:   North Florida Foundation for Research and Education;   Pfizer;   VA Office of Research and Development
Active, not recruiting - verified March 2017


A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs


Condition:   Rheumatoid Arthritis
Interventions:   Drug: ASP015K;   Drug: Placebo;   Biological: Etanercept
Sponsor:   Astellas Pharma Inc
Active, not recruiting - verified January 2017


A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment


Condition:   Rheumatoid Arthritis
Interventions:   Drug: ASP015K;   Drug: Placebo
Sponsor:   Astellas Pharma Inc
Active, not recruiting - verified April 2017


A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy


Condition:   Rheumatoid Arthritis
Interventions:   Drug: Humira (adalimumab);   Drug: SB5 (proposed biosimilar to adalimumab)
Sponsor:   Samsung Bioepis Co., Ltd.
Completed - verified November 2016


Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients


Condition:   Rheumatoid Arthritis
Interventions:   Biological: CFZ533;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified March 2017


Discovering the Antecedents of Rheumatoid Arthritis Flare


Condition:   Rheumatoid Arthritis
Intervention:  
Sponsor:   Rockefeller University
Recruiting - verified October 2016


The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients


Condition:   Rheumatoid Arthritis
Intervention:   Drug: corticotrophin 80 units
Sponsor:   Gaylis, Norman B., M.D.
Active, not recruiting - verified August 2016



Effect of Monoclonal Anti-IL6 Antibody (Tocilizumab) on the Cardiovascular Risk in Patients With Rheumatoid Arthritis


Condition:   Rheumatoid Arthritis
Intervention:   Other: Braquial ecography
Sponsors:   Hospital Universitario de Canarias;   Roche Pharma AG
Active, not recruiting - verified February 2017


Special Investigation in Patients With Rheumatoid Arthritis (Combo Study; Adalimumab With High Dose Methotrexate)


Condition:   Rheumatoid Arthritis
Intervention:  
Sponsor:   AbbVie (prior sponsor, Abbott)
Active, not recruiting - verified April 2017


Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.


Condition:   Rheumatoid Arthritis
Interventions:   Biological: Secukinumab (AIN457);   Biological: Placebo
Sponsor:   Novartis Pharmaceuticals
Terminated - verified June 2016


More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR)


Condition:   Rheumatoid Arthritis
Interventions:   Other: immediate therapeutic education;   Other: therapeutic education delayed
Sponsor:   Nantes University Hospital
Terminated - verified August 2016


Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)


Condition:   Rheumatoid Arthritis
Intervention:  
Sponsor:   AbbVie (prior sponsor, Abbott)
Completed - verified March 2017


Prospective Study on Intensive Early Rheumatoid Arthritis Treatment


Condition:   Rheumatoid Arthritis
Interventions:   Drug: adalimumab, plus prednisone;   Drug: adalimumab plus placebo
Sponsor:   IRCCS Policlinico S. Matteo
Completed - verified March 2017


Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis


Condition:   Rheumatoid Arthritis
Interventions:   Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
Sponsor:   Mallinckrodt
Completed - verified October 2016


A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.


Condition:   Rheumatoid Arthritis
Interventions:   Drug: Imatinib;   Drug: Methotrexate;   Drug: Imatinib Placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified April 2017

Refine Your Search Advanced Search